Could guselkumab be a disease-modifying agent in plaque psoriasis?February 25, 2018PsoriasisPsoriatic Arthritis
Ustekinumab quells aortic inflammation in patients with severe psoriasisFebruary 24, 2018PsoriasisPsoriatic Arthritis
Biologics have best chance of achieving PASI 90 in psoriasisFebruary 21, 2018PsoriasisPsoriatic Arthritis
Risankizumab outpaced ustekinumab for complete clearance of plaque psoriasisFebruary 19, 2018PsoriasisPsoriatic Arthritis
CV risk factors go undiagnosed, untreated in many psoriatic patientsFebruary 8, 2018Psoriatic ArthritisPsoriasis
Ixekizumab beats ustekinumab for fingernail psoriasis, hands downJanuary 18, 2018PsoriasisPsoriatic Arthritis
Novel herpes zoster vaccine is more cost effective than old vaccineJanuary 11, 2018Psoriatic Arthritis
Prior biologic exposure doesn’t diminish ixekizumab’s efficacyJanuary 8, 2018PsoriasisPsoriatic Arthritis
